Navigation Links
Testicular Cancer Survivors May Have Hormone Deficiency
Date:2/22/2010

Too little testosterone can affect quality of life, researchers say

MONDAY, Feb. 22 (HealthDay News) -- Testosterone deficiency in young male cancer survivors often causes low energy levels and reduced quality of life, and these patients may benefit from testosterone replacement therapy, a new study suggests.

About 15 percent of male cancer survivors experience testosterone deficiency, which is a late side effect of chemotherapy or radiation therapy.

In this study of 176 young male cancer survivors and 213 young men without cancer, English researchers looked at the association between testosterone levels, quality of life, self-esteem, fatigue and sexual function.

The young male cancer survivors reported reduced energy levels, impaired sexual function and a markedly reduced quality of life. These problems were most severe in those with testosterone deficiency.

However, the cancer survivors had no problems with self-esteem, sexual relationships or mental health.

"This is an important study demonstrating that low testosterone levels are common in male cancer survivors and associated with an impaired quality of life," said lead investigator Dr. Richard Ross, of the University of Sheffield. "However, the relationship between testosterone levels and quality of life is complex and appears to depend on a threshold level rather than on a direct correlation. We now need interventional trials with testosterone to determine which young male cancer survivors will benefit from replacement therapy."

The study was published online Feb. 22 in the journal Cancer.

More information

The U.S. Centers for Disease Control and Prevention has more about cancer and men.



-- Robert Preidt



SOURCE: Cancer, news release, Feb. 22, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Couples more likely to divorce if spouse develops cervical or testicular cancer
2. Testicular cancer gauge often not used
3. Mens Health Network Welcomes its Newest Member to its Nationwide Team, The Sean Kimerling Testicular Cancer Foundation
4. Preeclampsia Might Protect Against Testicular Cancer
5. Marijuana use linked to increased risk of testicular cancer
6. Marijuana Linked to Aggressive Testicular Cancer
7. Male Infertility Tied to Testicular Cancer Risk
8. Male infertility associated with testicular cancer
9. Researchers Spot Genes Linked to Testicular Cancer
10. Second gene linked to familial testicular cancer
11. Another Genetic Link to Testicular Cancer Is Found
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: